Skaana Management’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-79,406
Closed -$39.7K – 165
2022
Q4
$39.7K Sell
79,406
-17,261
-18% -$11K 0.01% 119
2022
Q3
$62K Sell
96,667
-7,500
-7% -$6.36K 0.02% 59
2022
Q2
$70K Sell
104,167
-11,289
-10% -$17.1K 0.02% 68
2022
Q1
$234K Sell
115,456
-39,947
-26% -$62.8K 0.04% 70
2021
Q4
$343K Buy
+155,403
New +$380K 0.05% 105

Other funds holding SRTAW

Skaana Management's SRTAW Position: Q1 2023 in Review

Skaana Management sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q1 2023, closing a stake of 79,406 shares — an estimated $39.7K sold.

Skaana Management first reported a position in SRTAW in Q4 2021 and held it in 5 quarters. The position peaked at $343K in Q4 2021. 11 funds tracked by Wall St. Rank hold SRTAW as of Q1 2023.

  • Skaana Management reported no remaining Strata Critical Medical Inc Warrants position as of Q1 2023 after selling out during the quarter.
  • Skaana Management sold 79,406 Strata Critical Medical Inc Warrants shares in Q1 2023, an estimated $39.7K.
  • Skaana Management first reported a position in Strata Critical Medical Inc Warrants in Q4 2021 and held it in 5 quarters.
  • Skaana Management's Strata Critical Medical Inc Warrants position peaked at $343K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q1 2023.

Based on Skaana Management's 13F filing for Q1 2023, filed 15 May 2023.